- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02659618
Identification of Serum Biomarkers for CD15+ Hypodense Neutrophils in Severe Asthma
Studieöversikt
Status
Betingelser
Detaljerad beskrivning
Neutrophils are implicated in the pathophysiology of multiple asthma phenotypes. It was shown in study IST Q4935s that low-density granulocytes (LDG) are elevated in the blood of patients with moderate or severe asthma. The greatest frequency and the highest percentages of LDG were observed in subjects with severe asthma. The LDG, which were first identified and characterized in systemic lupus erythematosus (SLE) patients, have been reported to display increased cytotoxicity for endothelial cells, increased tendency to form neutrophil extracellular traps, and increased production of tumor necrosis factor (TNF). It was also observed that the LDG expressed increased levels of CD15, which can facilitate attachment of activated platelets to the LDG. Identification of a putative serum biomarker that correlates with increased levels of the CD15+ LDG may be useful for the detection of neutrophil-associated inflammation in severe asthma.
Thirty subjects will be screened to identify 20 subjects with severe persistent asthma. The following data and/or samples will then be obtained within three weeks of the clinical assessment: (1) the percentages of LDG will be quantified by flow cytometry; (2) a blood sample will be collected into a PAXgene Blood tube and stored until shipped to Genentech for gene profiling analysis; and (3) a serum sample will be collected for measurement of total immunoglobulin E (IgE) and for future confirmation of potential biomarkers identified in the gene profiling analyses.
Studietyp
Inskrivning (Faktisk)
Kontakter och platser
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60612
- University Consultants in Allergy/Immunology
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Testmetod
Studera befolkning
Beskrivning
Inclusion Criteria:
- Physician diagnosis of severe persistent asthma;
- Positive skin test or radioallergosorbent test (RAST) for an aeroallergen;
- Male or female age 12-65 years;
- Non-smoker.
Exclusion Criteria:
- Asthma exacerbation requiring treatment with or increase in oral corticosteroids within 30 days prior to the study;
- Respiratory infection within 30 days prior to the study;
- Starting or requiring a change in allergen immunotherapy within 30 days prior to the study;
- Having been treated with Xolair within the past year;
- Requiring chronic immunosuppressive therapy;
- Having taken methotrexate, gold salts, cyclosporine, or macrolide antibiotics within 3 months prior to study;
- Having taken an investigational drug within 30 days prior to the study;
- Have a history of drug or alcohol abuse;
- Pregnancy
Studieplan
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
---|
Severe Persistent Asthma
All subjects will have severe persistent asthma diagnosed by a doctor.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Percentage of low density granulocytes (LDG) in the peripheral blood mononuclear cell (PBMC)
Tidsram: Visit 1 day
|
Visit 1 day
|
|
mRNA levels in severe asthmatics as analyzed by gene profiling analysis
Tidsram: Visit 1 day
|
Messenger ribonucleic acid (mRNA) expression levels for blood leukocyte proteins.
|
Visit 1 day
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Number of Participants with elevated LDG levels in severe asthmatics using gene profiling analysis on a single PAXgene tube sample
Tidsram: Visit 1 day
|
Visit 1 day
|
|
Serum samples will be collected and analyzed for measurement of total IgE
Tidsram: Visit 1 day
|
Correlation between LDG in severe asthma and biomarkers identified in gene profiling analysis
|
Visit 1 day
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- ML29345
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Svår långvarig astma
-
Amber Ophthalmics, Inc.RekryteringKorneal persistent epiteldefektFörenta staterna
-
Pfizer's Upjohn has merged with Mylan to form Viatris...AvslutadPulmonell hypertoni, familjär persistent, hos nyföddaFörenta staterna, Belgien, Storbritannien, Spanien, Danmark, Tyskland, Sverige, Kanada, Frankrike, Italien, Nederländerna, Norge
-
Vivek ReddyRekryteringLångvarig Persistent AFFörenta staterna
-
University of FloridaMallinckrodtIndragenPersistent fetalt cirkulationssyndrom | Ihållande pulmonell hypertoni hos nyfödda | Hypertoni, lung, hos nyfödda, persistentFörenta staterna
-
Moens MaartenVrije Universiteit BrusselRekryteringRyggmärgsstimulering | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Moens MaartenRekryteringMisslyckad Ryggkirurgi Syndrom | Persistent Spinal Pain Syndrome Typ 2Belgien
-
Yune ZhaoOkänd
-
Prof. Dr. med. Ingo EitelRekryteringIcke-valvulärt förmaksflimmer (NVAF): Paroxysmal, persistent, permanentTyskland
-
Ankara City Hospital BilkentOkändGraviditetsrelaterad | Foster; Omlopp
-
National Heart, Lung, and Blood Institute (NHLBI)AvslutadLungsjukdomar | Persistent fetalt cirkulationssyndrom